Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Theravance Biopharma
Theravance Biopharma
(TBPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Vibativ
Telavancin
2011-09-02
2027
Pneumonia
,
Cross infection
,
Bacterial infections
,
Infectious skin diseases
,
Streptococcal infections
,
Bacterial pneumonia
,
Staphylococcal infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Telavancin
bacterial infections
,
chronic kidney failure
,
kidney diseases
,
gram-positive bacterial infections
,
wound infection
,
abscess
,
ulcer
,
burns
,
cellulitis
,
staphylococcal infections
,
bacterial pneumonia
,
staphylococcal skin infections
,
bacteremia
,
healthcare-associated pneumonia
,
hemorrhage
,
subarachnoid hemorrhage
,
infections
,
pneumonia
,
communicable diseases
,
pregnancy
Benzocaine
leukemia
,
hematologic neoplasms
,
cancer pain
,
non-hodgkin lymphoma
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
t-cell lymphoma
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
lymphoid leukemia
,
oncogenes
,
neoplasms
,
colorectal neoplasms
,
colonic neoplasms
,
rectal neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
sarcoma
,
atopic dermatitis
,
eczema
,
dermatitis
,
chronic renal insufficiency
,
kidney diseases
,
anemia
,
neoplasm metastasis
,
hyperparathyroidism
,
thrombocytopenic purpura idiopathic
,
thrombocytopenia
,
thrombocytopenic purpura
,
psoriasis
,
secondary hyperparathyroidism
,
primary hyperparathyroidism
,
hypercalcemia
,
chronic kidney failure
,
purpura
,
hematologic diseases
,
hemostatic disorders
,
psoriatic arthritis
,
arthritis
,
gout
Ampreloxetine
drug interactions
,
hypertension
,
myofascial pain syndromes
,
fibromyalgia
,
shy-drager syndrome
,
atrophy
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
orthostatic hypotension
,
hypotension
,
pure autonomic failure
,
parkinson disease
,
multiple system atrophy
Doconexent
ovarian neoplasms
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
b-cell lymphoma marginal zone
,
non-hodgkin lymphoma
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
non-small-cell lung carcinoma
,
lung neoplasms
,
breast neoplasms
,
neoplasms
,
follicular lymphoma
,
b-cell lymphoma
,
mantle-cell lymphoma
,
respiratory distress syndrome
,
acute lung injury
,
urologic neoplasms
,
transitional cell carcinoma
,
multiple myeloma
,
leukemia
,
lymphoid leukemia
,
biliary tract neoplasms
,
esophageal neoplasms
,
precancerous conditions
,
monoclonal gammopathy of undetermined significance
,
pancreatic neoplasms
,
head and neck neoplasms
,
proteinuria
,
iga glomerulonephritis
Aspartame
rett syndrome
AXELOPRAN
constipation
,
opioid-induced constipation
,
healthy volunteers/patients
BATEFENTEROL
chronic obstructive pulmonary disease
,
lung diseases
Bevifimod
neoplasms
,
stomach neoplasms
,
breast neoplasms
,
neoplasm metastasis
CEFILAVANCIN
staphylococcal skin infections
,
staphylococcal infections
Corticorelin
prostatic neoplasms
,
chronic kidney failure
,
renal insufficiency
,
hyperparathyroidism
,
secondary hyperparathyroidism
,
kidney diseases
,
renal dialysis
,
carotid intima-media thickness
,
cardiovascular diseases
,
vascular calcification
,
calcinosis
FELCISETRAG
gastrointestinal motility
,
critical illness
Izencitinib
inflammatory bowel diseases
,
intestinal diseases
,
healthy volunteers/patients
,
crohn disease
,
ulcerative colitis
,
colitis
,
ulcer
Lotamilast
healthy volunteers/patients
,
low back pain
,
back pain
,
migraine disorders
,
schizophrenia
,
pharmacokinetics
,
pharmacological phenomena
,
chronic obstructive pulmonary disease
,
respiration disorders
,
bronchiolitis obliterans syndrome
,
obstructive lung diseases
,
cystic fibrosis
,
breast neoplasms
,
type 2 diabetes mellitus
,
insulin resistance
,
pain
,
lung diseases
,
bronchiectasis
,
major depressive disorder
,
fibrosis
,
social phobia
Remetinostat
healthy volunteers/patients
,
low back pain
,
back pain
,
migraine disorders
,
schizophrenia
,
pharmacokinetics
,
pharmacological phenomena
,
chronic obstructive pulmonary disease
,
respiration disorders
,
bronchiolitis obliterans syndrome
,
obstructive lung diseases
,
cystic fibrosis
,
breast neoplasms
,
type 2 diabetes mellitus
,
insulin resistance
,
pain
,
lung diseases
,
bronchiectasis
,
major depressive disorder
,
fibrosis
,
social phobia
Usistapide
liver failure
,
hepatic insufficiency
,
renal insufficiency
,
hypertension
,
hepatitis c
,
hepatitis
,
hepatitis a
,
neoplasms
,
overactive urinary bladder
,
parkinson disease
,
central nervous system diseases
,
brain diseases
,
movement disorders
,
neurodegenerative diseases
,
head and neck neoplasms
,
cough
,
schizophrenia
,
nervous system diseases
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
leukemia
,
myelodysplastic syndromes
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
preleukemia
,
blast crisis
,
lymphoid leukemia
,
melanoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
esophageal neoplasms
,
panic disorder
,
alcoholism
,
postoperative pain
,
osteoarthritis
,
neuralgia
,
postherpetic neuralgia
,
general anesthesia
,
glioblastoma
,
astrocytoma
,
anesthesia
,
muscle relaxation
,
delayed emergence from anesthesia
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use